Ryclora Liquid
NDC Package 15370-150-99
Package Information
Ryclora (dexchlorpheniramine maleate) liquids is perennial and seasonal allergic rhinitisVasomotor rhinitisAllergic conjunctivitis due to inhalant allergens and foodsMild, uncomplicated allergic skin manifestations of urticaria and angioedemaAmelioration of allergic reactions to blood or plasmaDermographismAs therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. This formulation utilizes a liquid delivery system. Marketed by Carwin Pharmaceutical Associates, Llc, this product is identified by NDC 15370-150 and is authorized under FDA application ANDA202520.
Identification & Billing
- RxCUI: 2183907 - dexchlorpheniramine maleate 2 MG in 5 mL Oral Solution
- RxCUI: 2183907 - dexchlorpheniramine maleate 0.4 MG/ML Oral Solution
- RxCUI: 2183907 - dexchlorpheniramine 2 MG per 5 ML Oral Solution
- RxCUI: 2183912 - RyClora 2 MG in 5 mL Oral Solution
- RxCUI: 2183912 - dexchlorpheniramine maleate 0.4 MG/ML Oral Solution [Ryclora]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 15370 - Carwin Pharmaceutical Associates, Llc
- 15370-150 - Ryclora
- 15370-150-99 - 20 mL in 1 BOTTLE, PLASTIC
- 15370-150 - Ryclora
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (15370-150). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 15370-150-99 identifies a specific commercial package of 20 ml in 1 bottle, plastic of Ryclora, a human prescription drug labeled by Carwin Pharmaceutical Associates, Llc. This liquid is formulated for oral use and contains dexchlorpheniramine maleate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Carwin Pharmaceutical Associates, Llc on October 07, 2018. The current certification is valid through December 31, 2026.
How is this Carwin Pharmaceutical Associates, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 15370015099. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.